Suiseng® is the new combined vaccine against neonatal piglet diarrhoea caused by E. coli and Clostridium perfringens type C and sudden death of sows caused by Clostridium novyi. The vaccine incorporates a new generation adjuvant based on ginseng saponins: Hipramune®-G.

The vaccine is launched onto the European Union market using a decentralized registration process. With this new product, Hipra and its R&D department clearly show their involvement in the search for innovative solutions to everyday problems of veterinarians and farmers and it is launched at both the key national and international markets for global livestock production.

Suiseng incorporates a new generation water-based ginseng saponin adjuvant that induces more powerful immunity than conventional water-based vaccines with maximum safety for the animals, thus becoming an innovative and exclusive vaccine within its market.

Suiseng is available in 10, 25 and 50-dose presentations.

Further Reading

-

Find out more information on the diseases mentioned in this article by clicking here.